BioSpace News Archive

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Dr. Cooper earned his Doctorate and Master Degrees in Microbiology at the University of Texas - Austin in 1989, and 1983, respectively.

ReddyPort®, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market, announced today that US Patent No. 11,222,648 has been issued by the US Patent Office covering a positive pressure ventilation (PPV) microphone system, nebulizer, and related methods.

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, announced that Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes, will participate in an upcoming corporate event hosted by Oppenheimer & Co.

Ambrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference.

Sanofi was recognized as one of the most sustainability-committed companies in an ESG Evaluation performed by Standard & Poor’s Global Ratings.

Fulgent Genetics, Inc. announced that members of its management team are scheduled to virtually participate in Oppenheimer’s 32nd Annual Healthcare Conference on Tuesday, March 15, 2022.

On December 15, 2020, Radius announced a discovery research collaboration with Massachusetts General Hospital to evaluate novel oral salt-inducible kinase inhibitors in an array of musculoskeletal diseases.

Sarepta Therapeutics, Inc. announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications.

CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, announced 510 clearance from the U.S. Food and Drug Administration for the addition of Fusation™ anchors to the F3D-C2 Cervical Stand-alone Fusion System.